Tirdzniecība CVS Health - CVS CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Tirdzniecības Nosacījumi
| Starpība | 0.20 | ||||||||
|
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.030779% | ||||||||
|
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.013666% | ||||||||
| Nakts laika nodeva | 22:00 (UTC) | ||||||||
| Min. tirgotais daudzums | 1 | ||||||||
| Valūta | USD | ||||||||
| Drošības rezerve | 20% | ||||||||
| Fondu birža | United States of America | ||||||||
| Tirdzniecības komisija | 0% |
*Information provided by Capital.com
CVS Health Corp ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Galvenie Statistikas Dati
| Iepriekš. aizvērt* | 87.36 |
| Atvērt* | 86.38 |
| Izmaiņas par 1 gadu* | -18.85% |
| Dienas Diapazons* | 86.04 - 86.56 |
| 52 ned Diapazons | 84.82-111.25 |
| Vidējais apjoms (10 dienas) | 11.52M |
| Vidējais apjoms (3 mēneši) | 149.50M |
| Tirgus Kapitalizācija | 115.92B |
| Cenas/Peļņas Attiecība | 37.49 |
| Izvietotās Akcijas | 1.31B |
| Ieņēmumi | 315.23B |
| EPS | 2.35 |
| Dividende (Ienesīgums %) | 2.74314 |
| Beta | 0.66 |
| Nākamās Peļņas Datums | Feb 8, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
|---|---|---|---|---|---|---|
| Feb 1, 2023 | 87.36 | -0.55 | -0.63% | 87.91 | 88.10 | 86.53 |
| Jan 31, 2023 | 88.09 | 1.24 | 1.43% | 86.85 | 88.41 | 86.85 |
| Jan 30, 2023 | 86.98 | -0.82 | -0.93% | 87.80 | 88.29 | 86.91 |
| Jan 27, 2023 | 87.68 | 0.03 | 0.03% | 87.65 | 88.04 | 86.92 |
| Jan 26, 2023 | 87.55 | 1.18 | 1.37% | 86.37 | 87.69 | 85.95 |
| Jan 25, 2023 | 85.68 | 0.63 | 0.74% | 85.05 | 85.94 | 84.75 |
| Jan 24, 2023 | 85.95 | -0.47 | -0.54% | 86.42 | 86.91 | 85.84 |
| Jan 23, 2023 | 87.13 | 0.28 | 0.32% | 86.85 | 87.38 | 86.51 |
| Jan 20, 2023 | 86.93 | -0.41 | -0.47% | 87.34 | 87.41 | 86.69 |
| Jan 19, 2023 | 87.40 | 0.27 | 0.31% | 87.13 | 88.22 | 86.94 |
| Jan 18, 2023 | 88.09 | -1.36 | -1.52% | 89.45 | 89.64 | 87.96 |
| Jan 17, 2023 | 89.26 | -0.74 | -0.82% | 90.00 | 90.43 | 89.03 |
| Jan 13, 2023 | 89.83 | 1.20 | 1.35% | 88.63 | 90.33 | 88.45 |
| Jan 12, 2023 | 89.11 | -0.55 | -0.61% | 89.66 | 89.90 | 88.94 |
| Jan 11, 2023 | 89.71 | -1.87 | -2.04% | 91.58 | 91.58 | 89.29 |
| Jan 10, 2023 | 90.56 | 0.31 | 0.34% | 90.25 | 91.29 | 88.40 |
| Jan 9, 2023 | 91.44 | -0.65 | -0.71% | 92.09 | 93.18 | 91.33 |
| Jan 6, 2023 | 91.53 | 0.55 | 0.60% | 90.98 | 91.86 | 90.81 |
| Jan 5, 2023 | 90.24 | -1.21 | -1.32% | 91.45 | 92.06 | 90.07 |
| Jan 4, 2023 | 91.93 | -0.85 | -0.92% | 92.78 | 93.31 | 91.53 |
CVS Health Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Kopējie ienākumi | 177546 | 184786 | 194579 | 256776 | 268706 | 292111 |
| Ienākumi | 177546 | 184786 | 194579 | 256776 | 268706 | 292111 |
| Cost of Revenue, Total | 146533 | 153448 | 156447 | 158719 | 163981 | 175803 |
| Bruto Peļņa | 31013 | 31338 | 38132 | 98057 | 104725 | 116308 |
| Kopējie Darbības Izdevumi | 167803 | 175248 | 190558 | 244868 | 256235 | 279370 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 18448 | 18809 | 21368 | 396 | 461 | 523 |
| Neparedzēti Izdevumi (Ienākumi) | 643 | 181 | 6149 | 559 | 1503 | 2373 |
| Other Operating Expenses, Total | 2179 | 2810 | 6594 | 85194 | 90290 | 100671 |
| Darbības Izdevumi | 9743 | 9538 | 4021 | 11908 | 12471 | 12741 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -1078 | -1062 | -2619 | -3035 | -2907 | -2503 |
| Citi, Neto | -28 | -208 | 4 | 124 | 206 | 182 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | 8637 | 8268 | 1406 | 8997 | 9770 | 10420 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | 5320 | 5131 | -696 | 6631 | 7201 | 7898 |
| Mazākuma Interese | -2 | -1 | 2 | 3 | -13 | 12 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | 5318 | 5130 | -694 | 6634 | 7188 | 7910 |
| Ārkārtas Posteņi Kopā | -1 | 1492 | 100 | 0 | -9 | 0 |
| Neto Ienākumi | 5317 | 6622 | -594 | 6634 | 7179 | 7910 |
| Total Adjustments to Net Income | -26 | -16 | -3 | 0 | 0 | |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 5292 | 5114 | -697 | 6634 | 7188 | 7910 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 5291 | 6606 | -597 | 6634 | 7179 | 7910 |
| Atšķaidītie Neto Ienākumi | 5291 | 6606 | -597 | 6634 | 7179 | 7910 |
| Atšķaidītie Ienākumi par Akcijām | 1079 | 1024 | 1044 | 1305 | 1314 | 1329 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 4.90454 | 4.99414 | -0.66762 | 5.08352 | 5.47032 | 5.95184 |
| Dividends per Share - Common Stock Primary Issue | 1.7 | 2 | 2 | 2 | 2 | 2 |
| Atšķaidītā Normalizētā Peļņa par Akciju | 5.2716 | 5.10383 | 3.16078 | 5.51501 | 6.31339 | 7.27044 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 69097 | 72616 | 73794 | 76604 | 76826 |
| Ienākumi | 69097 | 72616 | 73794 | 76604 | 76826 |
| Cost of Revenue, Total | 40894 | 43520 | 45011 | 46378 | 45509 |
| Bruto Peļņa | 28203 | 29096 | 28783 | 30226 | 31317 |
| Kopējie Darbības Izdevumi | 65520 | 68290 | 71096 | 74464 | 73336 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 8881 | 8829 | 9190 | ||
| Neparedzēti Izdevumi (Ienākumi) | 41 | 40 | 814 | 1478 | 525 |
| Other Operating Expenses, Total | 15704 | 15901 | 16081 | 26608 | 27302 |
| Darbības Izdevumi | 3577 | 4326 | 2698 | 2140 | 3490 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -657 | -636 | -602 | -608 | -586 |
| Citi, Neto | 50 | 45 | 49 | 38 | 42 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | 2970 | 3735 | 2145 | 1570 | 2946 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | 2224 | 2791 | 1587 | 1296 | 2313 |
| Mazākuma Interese | -1 | -8 | 11 | 10 | -1 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | 2223 | 2783 | 1598 | 1306 | 2312 |
| Neto Ienākumi | 2223 | 2783 | 1598 | 1306 | 2312 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 2223 | 2783 | 1598 | 1306 | 2312 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 2223 | 2783 | 1598 | 1306 | 2312 |
| Atšķaidītie Neto Ienākumi | 2223 | 2783 | 1598 | 1306 | 2312 |
| Atšķaidītie Ienākumi par Akcijām | 1322 | 1327 | 1329 | 1338 | 1328 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 1.68154 | 2.09721 | 1.20241 | 0.97608 | 1.74096 |
| Dividends per Share - Common Stock Primary Issue | 0.5 | 0.5 | 0.5 | 0.5 | 0.55 |
| Atšķaidītā Normalizētā Peļņa par Akciju | 1.70477 | 2.08539 | 1.65557 | 1.88793 | 2.05135 |
| Ārkārtas Posteņi Kopā | 0 |
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 31042 | 31229 | 45243 | 50302 | 56369 | 60008 |
| Nauda un Īstermiņa Ieguldījumi | 3458 | 1807 | 6581 | 8056 | 10854 | 12525 |
| Nauda un Ekvivalenti | 3371 | 1696 | 4059 | 5683 | 7854 | 9408 |
| Īstermiņa Ieguldījumi | 87 | 111 | 2522 | 2373 | 3000 | 3117 |
| Debitoru Parādu Kopsumma, Neto | 12164 | 13181 | 17631 | 19617 | 21742 | 24431 |
| Accounts Receivable - Trade, Net | 12164 | 13181 | 17631 | 17236 | 7101 | 7932 |
| Total Inventory | 14760 | 15296 | 16450 | 17516 | 18496 | 17760 |
| Other Current Assets, Total | 660 | 945 | 4581 | 5113 | 5277 | 5292 |
| Total Assets | 94462 | 95131 | 196456 | 222449 | 230715 | 232999 |
| Property/Plant/Equipment, Total - Net | 10175 | 10292 | 11349 | 32904 | 33335 | 32018 |
| Property/Plant/Equipment, Total - Gross | 22802 | 24290 | 26869 | 49794 | 52035 | 52672 |
| Accumulated Depreciation, Total | -12627 | -13998 | -15520 | -16890 | -18700 | -20654 |
| Goodwill, Net | 38249 | 38451 | 78678 | 79749 | 79552 | 79121 |
| Intangibles, Net | 13511 | 13630 | 36524 | 33121 | 31142 | 29026 |
| Other Long Term Assets, Total | 1485 | 1529 | 8930 | 9059 | 9505 | 9801 |
| Total Current Liabilities | 26250 | 30648 | 44009 | 53303 | 62017 | 67807 |
| Accounts Payable | 17397 | 19218 | 26437 | 30972 | 34869 | 38682 |
| Accrued Expenses | 6937 | 6609 | 10711 | 13656 | 15810 | 19229 |
| Notes Payable/Short Term Debt | 1874 | 1276 | 720 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 42 | 3545 | 1265 | 3781 | 5440 | 4205 |
| Total Liabilities | 57632 | 57440 | 138231 | 158585 | 161326 | 157924 |
| Total Long Term Debt | 25615 | 22181 | 71444 | 64699 | 59207 | 51971 |
| Long Term Debt | 25615 | 22181 | 71444 | 63918 | 58157 | 50721 |
| Deferred Income Tax | 4214 | 2996 | 7677 | 7294 | 6794 | 6270 |
| Minority Interest | 4 | 4 | 318 | 306 | 312 | 306 |
| Other Liabilities, Total | 1549 | 1611 | 14783 | 32983 | 32996 | 31570 |
| Total Equity | 36830 | 37691 | 58225 | 63864 | 69389 | 75075 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 17 | 17 | 45440 | 45972 | 46513 | 47377 |
| Additional Paid-In Capital | 31618 | 32079 | ||||
| Retained Earnings (Accumulated Deficit) | 38983 | 43556 | 40911 | 45108 | 49640 | 54906 |
| Treasury Stock - Common | -33483 | -37796 | -28228 | -28235 | -28178 | -28173 |
| Other Equity, Total | -305 | -165 | 5 | 245 | 200 | 187 |
| Total Liabilities & Shareholders’ Equity | 94462 | 95131 | 196456 | 222449 | 230715 | 232999 |
| Total Common Shares Outstanding | 1061 | 1014 | 1295 | 1302 | 1310 | 1322 |
| Long Term Investments | 15732 | 17314 | 20812 | 23025 | ||
| Other Current Liabilities, Total | 4876 | 4894 | 5898 | 5691 | ||
| Unrealized Gain (Loss) | 97 | 774 | 1214 | 778 | ||
| Capital Lease Obligations | 781 | 1050 | 1250 | |||
| Total Preferred Shares Outstanding | 0 | 0 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 55719 | 56559 | 60842 | 60008 | 61483 |
| Nauda un Īstermiņa Ieguldījumi | 8788 | 10125 | 12841 | 12525 | 11342 |
| Nauda un Ekvivalenti | 5598 | 7119 | 9826 | 9408 | 8442 |
| Īstermiņa Ieguldījumi | 3190 | 3006 | 3015 | 3117 | 2900 |
| Debitoru Parādu Kopsumma, Neto | 23855 | 24164 | 25283 | 24431 | 26451 |
| Accounts Receivable - Trade, Net | 18304 | 18976 | 8398 | 7932 | 8728 |
| Total Inventory | 17618 | 16979 | 17399 | 17760 | 18160 |
| Other Current Assets, Total | 5458 | 5291 | 5319 | 5292 | 5530 |
| Total Assets | 229606 | 231164 | 234891 | 232999 | 232873 |
| Property/Plant/Equipment, Total - Net | 33153 | 33140 | 33233 | 32018 | 31645 |
| Goodwill, Net | 79552 | 79552 | 79121 | 79121 | 79060 |
| Intangibles, Net | 30639 | 30080 | 29545 | 29026 | 28543 |
| Long Term Investments | 21025 | 22136 | 22370 | 23025 | 22595 |
| Other Long Term Assets, Total | 9518 | 9697 | 9780 | 9801 | 9547 |
| Total Current Liabilities | 60104 | 59311 | 64709 | 67807 | 69780 |
| Accounts Payable | 35358 | 36691 | 39468 | 38682 | 41570 |
| Accrued Expenses | 16018 | 16539 | 17871 | 19229 | 18388 |
| Notes Payable/Short Term Debt | 252 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 2422 | 60 | 1561 | 4205 | 4217 |
| Other Current Liabilities, Total | 6054 | 6021 | 5809 | 5691 | 5605 |
| Total Liabilities | 158756 | 157920 | 160583 | 157924 | 159043 |
| Total Long Term Debt | 59270 | 59294 | 56832 | 51971 | 52063 |
| Long Term Debt | 59270 | 59294 | 56832 | 51971 | 52063 |
| Deferred Income Tax | 6610 | 6557 | 6329 | 6270 | 5829 |
| Minority Interest | 314 | 321 | 310 | 306 | 310 |
| Other Liabilities, Total | 32458 | 32437 | 32403 | 31570 | 31061 |
| Total Equity | 70850 | 73244 | 74308 | 75075 | 73830 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 46727 | 46995 | 47133 | 47377 | 47677 |
| Retained Earnings (Accumulated Deficit) | 51203 | 53331 | 54264 | 54906 | 56488 |
| Treasury Stock - Common | -28102 | -28252 | -28166 | -28173 | -30145 |
| Unrealized Gain (Loss) | 828 | 977 | 904 | 778 | -377 |
| Other Equity, Total | 194 | 193 | 173 | 187 | 187 |
| Total Liabilities & Shareholders’ Equity | 229606 | 231164 | 234891 | 232999 | 232873 |
| Total Common Shares Outstanding | 1313 | 1318 | 1321 | 1322 | 1306 |
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Nauda no Darbības | 10141 | 8007 | 8865 | 12848 | 15865 | 18265 |
| Cash Receipts | 172310 | 176594 | 186519 | 248393 | 264327 | 284219 |
| Cash Payments | -142511 | -146469 | -148821 | -149655 | -158636 | -165783 |
| Cash Taxes Paid | -3060 | -2909 | -2383 | -2717 | -2929 | -3195 |
| Samaksātie Procenti Naudā | -1140 | -1072 | -2803 | -2954 | -2904 | -2469 |
| Izmaiņas Apgrozāmajā Kapitālā | -15458 | -18137 | -23647 | -80219 | -83993 | -94507 |
| Nauda no Ieguldījumu Darbībām | -2470 | -2877 | -43285 | -3339 | -5534 | -5261 |
| Kapitālie Izdevumi | -2224 | -1918 | -2037 | -2457 | -2437 | -2520 |
| Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -246 | -959 | -41248 | -882 | -3097 | -2741 |
| Nauda no Darbībām ar Finansēšanu | -6761 | -6751 | 36819 | -7654 | -7696 | -11356 |
| Naudas Plūsma Finansēšanas Posteņos | -142 | -72 | 350 | 59 | 337 | -13 |
| Total Cash Dividends Paid | -1840 | -2049 | -2038 | -2603 | -2624 | -2625 |
| Akciju Izsniegšana (Atkāpšanās), Neto | -4165 | -4032 | 242 | 210 | 264 | 549 |
| Parādu Izsniegšana (Atkāpšanās), Neto | -614 | -598 | 38265 | -5320 | -5673 | -9267 |
| Ārvalstu Valūtas Ietekme | 2 | 1 | -4 | |||
| Neto Izmaiņas Naudā | 912 | -1620 | 2395 | 1855 | 2635 | 1648 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Cash From Operating Activities | 2892 | 8739 | 14260 | 18265 | 3563 |
| Cash Receipts | 66487 | 136621 | 209104 | 284219 | 74192 |
| Cash Payments | -39171 | -79316 | -122129 | -165783 | -44365 |
| Cash Taxes Paid | -44 | -1552 | -2397 | -3195 | -96 |
| Cash Interest Paid | -876 | -1263 | -2095 | -2469 | -782 |
| Changes in Working Capital | -23504 | -45751 | -68223 | -94507 | -25386 |
| Cash From Investing Activities | -1867 | -2974 | -3821 | -5261 | -1993 |
| Capital Expenditures | -829 | -1315 | -1923 | -2520 | -1082 |
| Other Investing Cash Flow Items, Total | -1038 | -1659 | -1898 | -2741 | -911 |
| Cash From Financing Activities | -3185 | -6558 | -8525 | -11356 | -2650 |
| Financing Cash Flow Items | 56 | -159 | -164 | -13 | -211 |
| Total Cash Dividends Paid | -656 | -1306 | -1965 | -2625 | -722 |
| Issuance (Retirement) of Stock, Net | 212 | 330 | 440 | 549 | -1703 |
| Issuance (Retirement) of Debt, Net | -2797 | -5423 | -6836 | -9267 | -14 |
| Net Change in Cash | -2160 | -793 | 1914 | 1648 | -1080 |
| Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7762 | 115316851 | 1721829 | 2022-09-30 | LOW |
| Capital World Investors | Investment Advisor | 4.6346 | 60896763 | 2060715 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.586 | 60258711 | 234645 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.4403 | 58344728 | -339582 | 2022-09-30 | LOW |
| Capital International Investors | Investment Advisor | 1.9717 | 25907490 | -351533 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7789 | 23374421 | 186288 | 2022-09-30 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 1.6592 | 21801147 | 696280 | 2022-09-30 | LOW |
| JP Morgan Asset Management | Investment Advisor | 1.5392 | 20224681 | 368634 | 2022-09-30 | LOW |
| BofA Global Research (US) | Research Firm | 1.1617 | 15264714 | 80812 | 2022-09-30 | LOW |
| Dodge & Cox | Investment Advisor/Hedge Fund | 1.0254 | 13472772 | -236945 | 2022-09-30 | LOW |
| Invesco Advisers, Inc. | Investment Advisor | 0.9993 | 13129851 | -500609 | 2022-09-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9936 | 13055500 | -67996 | 2021-12-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.9056 | 11899729 | 224538 | 2022-09-30 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7675 | 10085134 | -130262 | 2022-09-30 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7495 | 9847659 | -473501 | 2022-09-30 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.726 | 9539067 | -771778 | 2022-09-30 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 0.7187 | 9443400 | -8279 | 2022-09-30 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.6884 | 9045542 | -197163 | 2022-09-30 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.673 | 8843195 | -63183 | 2022-09-30 | LOW |
| Nordea Funds Oy | Investment Advisor | 0.6619 | 8697324 | -983166 | 2022-09-30 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group +485000+
Tirgotāji
65000+
Ikmēneša aktīvie klienti
$48000000+
Ikmēneša ieguldījumu apjoms
$28000000+
Izmēģināt tagad Izņemts katru mēnesi
Treidinga kalkulators
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Tirdzniecības komisija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Finanšu svira
20:1
- 20
- 100
- 500
- 1000
- 10000
Investīcija
Darījuma apjoms (Kredītplecs x Investīcija):
Atvēršana
Aizvēršana
Īss Garšs
CVS Company profile
Par CVS Health
CVS Health Corporation kopā ar tās meitasuzņēmumiem ir veselības risinājumu uzņēmums. Uzņēmuma segmenti ir šādi: aptiekas pakalpojumi, mazumtirdzniecība un veselības aprūpe, veselības aprūpes pabalsti un korporatīvie/pārējie segmenti. Aptieku pakalpojumu segments piedāvā virkni farmācijas pabalstu pārvaldības (PBM) risinājumu, tostarp plānu izstrādes piedāvājumus un administrēšanu, mazumtirdzniecības aptieku tīkla pārvaldības pakalpojumus, pasta aptieku pakalpojumus, specializētās aptiekas, klīniskos pakalpojumus, slimību pārvaldības pakalpojumus un medicīnas izdevumu pārvaldību. Mazumtirdzniecības/LTC segmentā tiek pārdotas recepšu zāles, kā arī dažādi veselības un labsajūtas produkti un plaša patēriņa preces. Veselības aprūpes pabalstu segments piedāvā virkni tradicionālo, brīvprātīgo un patērētāju vadīto veselības apdrošināšanas produktu un saistīto pakalpojumu. Sabiedrības pakalpojumi ietver veselības un labsajūtas pakalpojumus, veselības plānus, aptiekas pakalpojumus un recepšu zāļu iegādi. Sabiedrībai ir aptuveni 9900 mazumtirdzniecības vietu, vairāk nekā 1200 medicīnas klīnikas, farmācijas pabalstu pārvaldnieks.
| Industry: | Healthcare Facilities & Services (NEC) |
1 Cvs Dr
WOONSOCKET
RHODE ISLAND 02895-6146
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 485 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com